MSB 2.51% 97.0¢ mesoblast limited

here it goes again., page-9

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    Hi Big Dog,

    Well articulated.
    Having TEVA ratify the MPC technology confirms to me my strong belief and confidence in MSB's credentials.

    Yes, the market does need an update on the science and IMO, I would think this is very much due and forthcoming ( based on various recent analyst reports).

    Patience is Key to being an MSB shareholder ( as would be the case with any biotech).
    Always DYOR and good luck to all holders.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.